EXHIBIT 2 AGREEMENT OF REPORTING PERSONS The undersigned agree that this Schedule 13G dated May 4, 2001, is being filed with the Securities and Exchange Commission on behalf of each of Ralph Maddox Family Trust, Kathryn Mays Johnson 1999 Exempt Trust,...Schedule 13g • May 4th, 2001 • Mays L Lowry • Miscellaneous food preparations & kindred products
CUSIP No. 44926L300 ----------------------------- EXHIBIT 1 TO SCHEDULE 13G ------------------------- Keeley Asset Management Corp., Kamco Performance Limited Partnership and Kamco Limited Partnership No. 1 agree that, unless differentiated, this...Schedule 13g • February 4th, 2002 • Keeley Asset Management Corp • Accident & health insurance
Keeley Asset Management Corp., Kamco Performance Limited Partnership and Kamco Limited Partnership No. 1 agree that, unless differentiated, this Schedule 13G is filed on behalf of each of the parties.
CUSIP No. 166435107 ------------------------------------- EXHIBIT 1 TO SCHEDULE 13G Keeley Asset Management Corp., Kamco Thrift Partners Limited Partnership, John L. Keeley, Jr. and Barbara G. Keeley agree that, unless differentiated, this Schedule...Schedule 13g • February 11th, 2003 • Keeley Asset Management Corp • National commercial banks
Keeley Asset Management Corp., Kamco Thrift Partners Limited Partnership, John L. Keeley, Jr. and Barbara G. Keeley agree that, unless differentiated, this Schedule 13G is filed on behalf of each of the parties.
JOINT FILING AGREEMENTJoint Filing Agreement • October 4th, 2024 • Bizzarri Ugo • Services-nursing & personal care facilities
The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned each acknowledges that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained herein and therein, but shall not be responsible for the completeness and accuracy of the information concerning the other, except to the extent that he or it knows or has reason to believe that such information is inaccurate.
JOINT FILING AGREEMENTJoint Filing Agreement • December 17th, 2024 • Tigerex Holding LTD • Security brokers, dealers & flotation companies
In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13G referred to below) on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the American Depositary Shares of UP Fintech Holding Limited, a Cayman Islands company, and that this Agreement may be included as an Exhibit to such joint filing. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
AGREEMENTSchedule 13g • February 11th, 2008 • Harbinger Capital Partners Master Fund I, Ltd. • Retail-home furniture, furnishings & equipment stores
The undersigned agree that this Schedule 13G dated February 11, 2008 relating to the Common Stock ($0.01 par value per share) of Williams–Sonoma, Inc. shall be filed on behalf of the undersigned.
JOINT FILING AGREEMENTJoint Filing Agreement • December 20th, 2024 • Samsara BioCapital, L.P. • Pharmaceutical preparations
We, the undersigned, hereby express our agreement that the Schedule 13G (or any amendments thereto) relating to the Common Stock of Palvella Therapeutics, Inc. is filed on behalf of each of us.
JOINT FILING AGREEMENTJoint Filing Agreement • December 17th, 2024 • Commodore Capital Lp • Biological products, (no disgnostic substances)
The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned, and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the other, except to the extent that it knows or has reason to believe that such information is inaccurate.
Agreement The undersigned agree that this Schedule 13G and all amendments thereto, relating to the Common Stock of ARENA PHARMACEUTICALS, INC. shall be filed on behalf of the undersigned. DEERFIELD CAPITAL, L.P. By: J.E. Flynn Capital LLC, General...Schedule 13g • October 23rd, 2007 • Flynn James E • Pharmaceutical preparations
The undersigned agree that this Schedule 13G and all amendments thereto, relating to the Common Stock of ARENA PHARMACEUTICALS, INC. shall be filed on behalf of the undersigned.
CUSIP No. 743737108 ---------------------------------------- EXHIBIT 1 TO SCHEDULE 13G Keeley Asset Management Corp., Kamco Performance Limited Partnership and Kamco Limited Partnership No. 1 agree that, unless differentiated, this Schedule 13G is...Schedule 13g • February 11th, 2003 • Keeley Asset Management Corp • Railroads, line-haul operating
Keeley Asset Management Corp., Kamco Performance Limited Partnership and Kamco Limited Partnership No. 1 agree that, unless differentiated, this Schedule 13G is filed on behalf of each of the parties.
SCHEDULE 13G Amendment No. 6 (Name of Issuer)Schedule 13g • December 2nd, 2021
Private Capital Management, L.P. is filing as an Investment Adviser registered under section 203 of the Investment Advisers Act of 1940.
AGREEMENTSchedule 13g • July 23rd, 2004 • National Vision Inc • Retail-retail stores, nec
The undersigned agree that this Schedule 13G dated July 21, 2004 relating to the Common Stock of National Vision, Inc. shall be filed on behalf of the undersigned.
EXHIBIT I JOINT FILING AGREEMENTJoint Filing Agreement • December 10th, 2024 • Millennium Management LLC • Laboratory analytical instruments
This will confirm the agreement by and among the undersigned that the Schedule 13G filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the Common Stock, par value $0.001 per share, of Pacific Biosciences of California, Inc. will be filed on behalf of each of the persons and entities named below in accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.
Exhibit ASchedule 13g • February 24th, 2021 • Alpine Global Management, LLC • Motor vehicles & passenger car bodies
Pursuant to the instructions in Item 6 of Schedule 13G, the following lists the identity of each relevant entity that beneficially owns shares of the security class being reported on this Schedule 13G.
JOINT FILING AGREEMENTJoint Filing Agreement • December 16th, 2024 • Commodore Capital Lp • Pharmaceutical preparations
The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned, and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the other, except to the extent that it knows or has reason to believe that such information is inaccurate.
CUSIP No. 617358106 ----------------------------- EXHIBIT 1 TO SCHEDULE 13G ------------------------- John L. Keeley, Jr., Keeley Asset Management Corp., Kamco Performance Limited Partnership, Kamco Limited Partnership No. 1, John L. Keeley, Jr....Schedule 13g • February 4th, 2002 • Keeley Asset Management Corp • Trucking (no local)
John L. Keeley, Jr., Keeley Asset Management Corp., Kamco Performance Limited Partnership, Kamco Limited Partnership No. 1, John L. Keeley, Jr. Foundation and Keeley Investment Corp. agree that, unless differentiated, this Schedule 13G is filed on behalf of each of the parties.
AGREEMENT REGARDING JOINT FILING OF STATEMENT ON SCHEDULE 13D OR 13GJoint Filing Agreement • December 17th, 2024 • EcoR1 Capital, LLC • Pharmaceutical preparations
The undersigned agree to file jointly with the Securities and Exchange Commission (the “SEC”) any and all statements on Schedule 13D or Schedule 13G or Forms 3, 4 or 5(and any amendments or supplements thereto) required under section 13(d) and 16(a) of the Securities Exchange Act of 1934, as amended, in connection with purchases by the undersigned of the securities of any issuer. For that purpose, the undersigned hereby constitute and appoint EcoR1 Capital, LLC, a Delaware limited liability company, as their true and lawful agent and attorney-in-fact, with full power and authority for and on behalf of the undersigned to prepare or cause to be prepared, sign, file with the SEC and furnish to any other person all certificates, instruments, agreements and documents necessary to comply with section 13(d) and section 16(a) of the Securities Exchange Act of 1934, as amended, in connection with said purchases, and to do and perform every act necessary and proper to be done incident to the exe
Exhibit ASchedule 13g • February 24th, 2021 • Alpine Global Management, LLC • Services-prepackaged software
Pursuant to the instructions in Item 6 of Schedule 13G, the following lists the identity of each relevant entity that beneficially owns shares of the security class being reported on this Schedule 13G.
JOINT FILING AGREEMENTJoint Filing Agreement • December 17th, 2024 • Ever Best Trading Corp LTD • Abrasive, asbestos & misc nonmetallic mineral prods
Each of the undersigned agrees that (i) the statement on Schedule 13G relating to the Class A shares of ReTo Eco-Solutions, Inc. has been adopted and filed on behalf of each of them, (ii) all future amendments to such statement on Schedule 13G will, unless written notice to the contrary is delivered as described below, be jointly filed on behalf of each of them and (iii) the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, shall apply to each of them. This agreement may be terminated with respect to the obligations to jointly file future amendments to such statement on Schedule 13G as to any of the undersigned upon such person giving written notice thereof to each of the other persons signatory hereto, at the principal office thereof.
Joint Filing Agreement Pursuant to Rule 13d-1Joint Filing Agreement • August 7th, 2024 • Dellora Investments LP • Pharmaceutical preparations
This agreement is made pursuant to Rule 13d-l(k)(1) under the Securities Exchange Act of 1934, as amended (the "Act") by and among the parties listed below, each referenced to herein as a "Joint Filer". The Joint Filers agree that a statement of beneficial ownership as required by Sections 13(g) or 13(d) of the Act and the rules thereunder may be filed on each of his, her or its behalf on Schedule 13G or Schedule 13D, as appropriate, and that said joint filing may thereafter be amended by further joint filings. The Joint Filers state that they each satisfy the requirements for making a joint filing under Rule 13d-1(k).
Exhibit ISchedule 13g • July 7th, 2005 • Credit Suisse/ • Deep sea foreign transportation of freight
Nautilus is a Delaware limited partnership which was formed initially to purchase securities of Seabulk International, Inc. ("Seabulk"). Such securities were subsequently converted into the right to receive Common Stock of the Company in connection with the merger among the Company, SBLK Acquisition Corp., Corbulk LLC and Seabulk, and are the shares of Common Stock to which this Schedule 13G relates. Nautilus Intermediary is the general partner of Nautilus.
EXHIBIT A JOINT FILING AGREEMENTJoint Filing Agreement • March 14th, 2024 • ADAR1 Partners, LP • Pharmaceutical preparations
The undersigned hereby agree that the statement on Schedule 13G with respect to the shares of common stock, par value $0.0001 per share, of Homology Medicines, Inc. dated as of March 14, 2024 is, and any amendments thereto signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
Joint Filing AgreementJoint Filing Agreement • December 18th, 2024 • Diglife As • Services-miscellaneous amusement & recreation
In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, each of the undersigned hereby agrees to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13G referred to below) on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Class A ordinary shares, par value US$0.0001 per share, of NIP Group Inc., a company incorporated in the Cayman Islands, and that this Agreement may be included as an Exhibit to such joint filing. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
JOINT FILING AGREEMENTJoint Filing Agreement • March 13th, 2024 • Calm Waters Partnership • Aircraft parts & auxiliary equipment, nec
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, each of the undersigned hereby agrees to the joint filing with the other reporting person of a statement on Schedule 13G (including amendments thereto) with respect to the Common Stock, $0.001 par value, of CPI Aerostructures, Inc. and that this Agreement be included as an Exhibit to such joint filing.
EXHIBIT A JOINT FILING AGREEMENT The undersigned hereby agree that the statement on Schedule 13G with respect to the shares of common stock, par value $0.01 per share, of Merrimack Pharmaceuticals, Inc. dated as of February 22, 2024 is, and any...Joint Filing Agreement • February 22nd, 2024 • ADAR1 Partners, LP • Pharmaceutical preparations
The undersigned hereby agree that the statement on Schedule 13G with respect to the shares of common stock, par value $0.01 per share, of Merrimack Pharmaceuticals, Inc. dated as of February 22, 2024 is, and any amendments thereto signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
CUSIP No. 617358106 ----------------------- EXHIBIT 1 TO SCHEDULE 13G ------------------------- John L. Keeley, Jr., Keeley Asset Management Corp., Kamco Performance Limited Partnership, Kamco Limited Partnership No. 1, John L. Keeley, Jr. Foundation...Schedule 13g • February 9th, 2001 • Keeley Asset Management Corp • Trucking (no local)
John L. Keeley, Jr., Keeley Asset Management Corp., Kamco Performance Limited Partnership, Kamco Limited Partnership No. 1, John L. Keeley, Jr. Foundation and Keeley Investment Corp. agree that, unless differentiated, this Schedule 13G is filed on behalf of each of the parties.
AGREEMENT REGARDING JOINT FILING OF STATEMENT ON SCHEDULE 13D OR 13GJoint Filing Agreement • December 13th, 2024 • Stonepine Capital Management, LLC • Pharmaceutical preparations
The undersigned agree to file jointly with the Securities and Exchange Commission (the “SEC”) any and all statements on Schedule 13D or Schedule 13G or Forms 3, 4 or 5(and any amendments or supplements thereto) required under section 13(d) and 16(a) of the Securities Exchange Act of 1934, as amended, in connection with purchases by the undersigned of the securities of any issuer. For that purpose, the undersigned hereby constitute and appoint Stonepine Capital Management, LLC, a Delaware limited liability company, as their true and lawful agent and attorney-in-fact, with full power and authority for and on behalf of the undersigned to prepare or cause to be prepared, sign, file with the SEC and furnish to any other person all certificates, instruments, agreements and documents necessary to comply with section 13(d) and section 16(a) of the Securities Exchange Act of 1934, as amended, in connection with said purchases, and to do and perform every act necessary and proper to be done inci
Exhibit ASchedule 13g • July 8th, 2021 • Alpine Global Management, LLC • Services-prepackaged software
Pursuant to the instructions in Item 6 of Schedule 13G, the following lists the identity of each relevant entity that beneficially owns shares of the security class being reported on this Schedule 13G.
JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k)Joint Filing Agreement • November 14th, 2024 • Atlas Merchant Capital LLC • Blank checks
The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained herein and therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.
JOINT FILING AGREEMENTJoint Filing Agreement • December 18th, 2024 • D. E. Shaw & Co, L.P. • Real estate
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, each of the undersigned Reporting Persons hereby agrees to the joint filing, along with all other such Reporting Persons, on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Common Shares of Beneficial Interest, of Office Properties Income Trust, and that this Agreement be included as an Exhibit to such joint filing. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
JOINT FILING AGREEMENTJoint Filing Agreement • December 20th, 2024 • Suvretta Capital Management, LLC • Pharmaceutical preparations
The undersigned agree that this Schedule 13G dated December 20, 2024 relating to the Common stock, $0.001 par value per share, of Palvella Therapeutics, Inc. shall be filed on behalf of the undersigned.
Joint Filing AgreementJoint Filing Agreement • April 24th, 2024 • FJ Capital Management LLC • National commercial banks
The undersigned agree that this Schedule 13G, and all amendments thereto, relating to the Common Stock First Bancshares, Inc. (FBMS) shall be filed on behalf of the undersigned.
EXHIBIT A JOINT FILING AGREEMENTJoint Filing Agreement • February 23rd, 2024 • ADAR1 Partners, LP • Biological products, (no disgnostic substances)
The undersigned hereby agree that the statement on Schedule 13G with respect to the shares of common stock, par value $0.0001 per share, of AVROBIO, Inc. dated as of February 23, 2024 is, and any amendments thereto signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
EXHIBIT I JOINT FILING AGREEMENTJoint Filing Agreement • December 16th, 2024 • Integrated Core Strategies (Us) LLC • Pharmaceutical preparations
This will confirm the agreement by and among the undersigned that the Schedule 13G filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the Common Stock, par value $0.001 per share, of Pyxis Oncology, Inc. will be filed on behalf of each of the persons and entities named below in accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.
JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including any and all amendments...Joint Filing Agreement • February 13th, 2024 • Moreland Jane Ann • National commercial banks
This Joint Filing Agreement may be signed in any number of counterparts, each of which is deemed an original, but all of which, taken together, shall constitute one and the same instrument.
